Wall Street analysts forecast that Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating) will post earnings of $0.03 per share for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Cellebrite DI’s earnings. The lowest EPS estimate is $0.01 and the highest is $0.04. The business is expected to issue its […]
Veru (NASDAQ:VERU – Get Rating) had its target price increased by Brookline Capital Acquisition from $29.00 to $31.00 in a research note issued on Wednesday, Stock Target Advisor reports. The brokerage presently has a “buy” rating on the stock. Brookline Capital Acquisition’s target price would suggest a potential upside of 114.53% from the stock’s previous […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Veru Inc. (NASDAQ:VERU – Get Rating) – Investment analysts at Jefferies Financial Group boosted their FY2023 earnings estimates for Veru in a report issued on Monday, April 11th. Jefferies Financial Group analyst C. Howerton now expects that the company will post earnings of $0.01 per share for the year, up from their previous forecast of […]
Veru (NASDAQ:VERU – Get Rating) had its price target increased by HC Wainwright from $21.00 to $24.00 in a research report released on Tuesday, Marketbeat reports. They currently have a buy rating on the stock. Several other equities analysts have also issued reports on the stock. Zacks Investment Research lowered shares of Veru from a […]